Recent research shows that although testicular cancer survivors do not totally conform to the criteria for metabolic syndrome, past treatment with platinum-based chemotherapy increases its prevalence among survivors and may lead to a greater risk for heart disease in this patient population.
Results from the ongoing Platinum Study revealed the prevalence of risk factors for CVD among survivors of testicular cancer who received chemotherapy for their cancer.
Survivors of testicular cancer are more likely to develop metabolic syndrome after platinum-based chemotherapy.
Patients without insurance and those with Medicaid have an increased risk of presenting with advanced testicular cancer and cancer-related death compared with those who have insurance.
Patients with stage IIA testicular cancer gain a survival advantage from treatment with radiation therapy compared with chemotherapy.
A new study has uncovered four new genetic variants associated with increased risk of testicular cancer. Testing for these and all 21 previously identified variants using genetic sequencing identified men at higher risk of testicular cancer.
Scientists have developed a test that assesses 3 features of nonseminomatous germ cell tumor, a common kind of testicular cancer, to identify those patients at greatest risk of relapse.
Recent study explored whether chronic fatigue is more prevalent in survivors of testicular cancer than the general population.
Patients with testicular nonseminoma have significantly increased cardiovascular disease mortality after chemotherapy.
Compared with the vasectomy and control groups, infertile men had a higher risk of testis cancer, non-Hodgkin lymphoma, and all cancers.
Taking muscle-building supplements significantly increases likelihood of developing testicular cancer.
Individuals who've had testicular cancer may be at increased risk for prostate cancer, but the overall risk is low, according to a study.
An increase in incidence of testicular germ cell tumors in Hispanic adolescents and young adults in the United States has been observed.
A new analysis has found that rates of testicular cancer have been rising dramatically in recent years among young Hispanic American men, but not among their non-Hispanic counterparts.
Giving men with testicular cancer a single dose of chemotherapy alongside radiotherapy could improve the effectiveness of treatment and reduce the risk for long-term side effects, according to a new study.
Four newly identified genetic variants are associated with an increased risk of testicular cancer, according to a new study that examined the genomes of over 13,000 men.
The incidence of testicular germ cell tumors (TGCT) increased from 1992 to 2009, especially among Hispanic men.
Immediate health risks supersede lifetime radiation-induced cancer risk in patients undergoing computed tomography surveillance for testicular cancer.
Risk highest for nonseminoma and mixed histology tumors.
A large UK study found a wide variation between cancer types in patients who had visited their general practitioner 3 or more times before cancer diagnosis.
Only a relatively small proportion of second cancers in adults is related to routine radiotherapy administered for initial disease, according to the findings of a recent study.
Adult men who were thought to be rendered sterile due to chemotherapy for childhood cancer may be able to reproduce with the help of a surgical technique that has recently been shown to locate and extract viable sperm.
Men who received a diagnosis of testicular cancer after age 40 years were twice as likely to die of the disease, according to the findings of a recent study.
Use of marijuana may increase the risk of testicular cancer, according to a study presented at the Annual Meeting of the American Association for Cancer Research.
A recent study finds that smoking cannabis increases a man's risk of developing testicular cancer
Sign Up for Free e-newsletters
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Reflexology, Aromatherapy May Reduce Pain, Anxiety of Brachytherapy for Cervical Cancer
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Multimodal Follow-up Improved Postradiotherapy Sexual Health in Lower GI, Gynecologic Cancers
- Lung Cancer Screening Program In Ambulatory Clinics May Improve Detection Rates
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|